Latest News - Veeva Systems
Top Corporates Hub
Veeva Systems
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
09.10.2026 13:43
VEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
Veeva (VEEV) Stock May Be 11% Below Fair Value After Biotech Adoption News
09.10.2026 03:17
Veeva Systems has delivered a mixed share price story over recent years, which puts the focus firmly on whether the current market value lines up with the cash it can generate. With the stock now back near the spotlight after a solid multi year gain, the question is how well that price matches the stream of cash flows investors are effectively paying for. Over the past 3 years the stock has returned 31.9%, so a meaningful amount of investor capital now depends on whether the underlying cash...
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
08.10.2026 11:03
At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE: VEEV) will bring together leading biopharmas, emerging biotechs, CROs, and sites — including Duke University, Eli Lilly and Company, Pfizer, Sanofi, Tolmar, UCB, and the University of Pennsylvania — to explain how they are driving new ways of working across drug development and quality.
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
08.10.2026 11:03
At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE: VEEV) will bring together leading biopharmas, emerging biotechs, CROs, and sites — including Duke University, Eli Lilly and Company, Pfizer, Sanofi, Tolmar, UCB, and the University of Pennsylvania — to explain how they are driving new ways of working across drug development and quality.
Veeva Systems (NYSE:VEEV): Strong Growth Meets a High-Quality Technical Setup
08.10.2026 10:20
Veeva Systems pairs strong growth and margins with a consolidation breakout setup; valuation is the key risk to watch for growth stock investors.
Why Is Veeva Systems (VEEV) Drawing Attention After Reaching 175 Biotechs?
08.10.2026 09:13
Veeva Systems (NYSE:VEEV) reported that more than 175 emerging biotech companies now use its Veeva Basics platform for drug development. The firm said its Data Quality System has processed and cleaned information for over 1 million subjects across more than 1,000 clinical studies. Management framed both updates as steps toward more automated clinical trial data handling for life sciences customers. The rapid Veeva Basics uptake and DQS scale are one chapter in a broader Veeva Systems story...
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
06.10.2026 11:03
Veeva Systems (NYSE: VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cleaned data for more than 1 million subjects in more than 1,000 studies to accelerate the delivery of analysis-ready data and trial insights. With more than 500,000 automated queries, Veeva DQS has saved thousands of hours in data reconciliation for sites and sponsors.
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
29.09.2026 12:30
Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade)
27.09.2026 06:25
Veeva Systems was downgraded to neutral after a 40%+ rally as valuation looks stretched despite strong growth and Falcon AI demand. Click for more on VEEV stock.
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients
25.09.2026 06:10
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a global deployment of Veeva Vault CRM. Together, these developments highlight Veeva’s push to embed agentic AI across clinical, safety, quality, and commercial workflows, reinforcing its role as an end-to-end software partner for life sciences...
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
24.09.2026 11:03
Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol. By reusing an organization's existing standards and leveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures faster, more deterministic study builds.
Quality Management System Software Market Forecasts Growth from $11.73B (2026) to $20.43B by 2031, Profiling Veeva Systems, Siemens, PTC, SAP, Oracle & 15 Others
24.09.2026 10:29
The global Quality Management System (QMS) software market is projected to grow from USD 11.73 billion in 2026 to USD 20.43 billion by 2031, at an 11.7% CAGR. Growth is driven by cloud-based QMS platforms, AI-powered quality analytics, automated compliance workflows and integration with ERP, MES and PLM systems. SMEs are the fastest-growing customer segment, while document control and management holds the largest market share. North America leads the market, and Asia Pacific is the fastest-growi
Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
23.09.2026 09:57
The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, rising adverse event data, and adoption of AI, automation, NLP and cloud platforms. North America leads the market, while Asia-Pacific will grow fastest. Key players include Oracle, IQVIA, ArisGlobal, Parexel, ICON, Veeva Systems and RxLogix.Dublin, Sept. 23, 2026 (GLOBE NEWSWI
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today
22.09.2026 12:30
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
21.09.2026 12:06
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels
21.09.2026 11:03
Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.
2 Profitable Stocks to Keep an Eye On and 1 We Ignore
18.09.2026 10:00
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Veeva Systems (NYSE:VEEV) Combines Strong Growth With a High-Quality Technical Setup
16.09.2026 09:00
VEEV pairs strong growth, elite profitability, and a debt-free balance sheet with a constructive technical setup, though rich valuation remains a risk.
Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target
14.09.2026 06:02
Veeva Systems (NYSE:VEEV) is positioning artificial intelligence as an incremental growth opportunity beyond its previously stated goal of reaching $6 billion in revenue by 2030, according to executives speaking at a Wells Fargo healthcare technology event. Paul Shawah, Veeva’s EVP of Commercial St
Veeva Systems Unveils Falcon AI as Commercial Growth Gains Momentum
14.09.2026 05:02
Veeva Systems (NYSE:VEEV) CFO Brian Van Wagener said the company is expanding its artificial intelligence roadmap while continuing to see broad-based growth across its life sciences software portfolio. Speaking at Citi’s Tech Conference, Van Wagener described Veeva as a vertical software provider f